These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2899090

  • 1. Somatostatin enhances insulin-mediated glucose disposal in elderly subjects.
    Meneilly GS, Elahi D, Minaker KL, Rowe JW.
    J Clin Endocrinol Metab; 1988 Aug; 67(2):407-10. PubMed ID: 2899090
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin does not alter insulin-mediated glucose disposal.
    Meneilly GS, Elahi D, Minaker KL, Rowe JW.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):364-7. PubMed ID: 2885337
    [Abstract] [Full Text] [Related]

  • 3. Impairment of noninsulin-mediated glucose disposal in the elderly.
    Meneilly GS, Elahi D, Minaker KL, Sclater AL, Rowe JW.
    J Clin Endocrinol Metab; 1989 Mar; 68(3):566-71. PubMed ID: 2563735
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin infusion enhances hepatic glucose production during hyperglucagonemia.
    Meneilly GS, Minaker KL, Elahi D, Rowe JW.
    Metabolism; 1988 Mar; 37(3):252-6. PubMed ID: 2893970
    [Abstract] [Full Text] [Related]

  • 5. Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency.
    Nair KS.
    J Clin Endocrinol Metab; 1987 May; 64(5):896-901. PubMed ID: 2881943
    [Abstract] [Full Text] [Related]

  • 6. Effects of mild-to-moderate hyperglycaemia per se on glucose production and uptake in the elderly.
    Paolisso G, Marrazzo G, de Riu S, Sgambato S, Varricchio M, d'Onofrio F, Lefèbvre P.
    Eur J Med; 1992 Apr; 1(1):6-12. PubMed ID: 1341981
    [Abstract] [Full Text] [Related]

  • 7. Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion.
    Ambrosio MR, Campo M, Zatelli MC, Cella SG, Trasforini G, Margutti A, Rigamonti AE, Müller EE, degli Uberti EC.
    Neuroendocrinology; 1998 Aug; 68(2):123-8. PubMed ID: 9705579
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.
    Møller N, Bagger JP, Schmitz O, Jørgensen JO, Ovesen P, Møller J, Alberti KG, Orskov H.
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1789-93. PubMed ID: 7775624
    [Abstract] [Full Text] [Related]

  • 9. The dawn phenomenon does not occur in normal elderly subjects.
    Meneilly GS, Elahi D, Minaker KL, Rowe JW.
    J Clin Endocrinol Metab; 1986 Aug; 63(2):292-6. PubMed ID: 3522617
    [Abstract] [Full Text] [Related]

  • 10. Relationship between insulin-mediated glucose disposal by muscle and adipose tissue lipolysis in healthy volunteers.
    Pei D, Chen YD, Hollenbeck CB, Bhargava R, Reaven GM.
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3368-72. PubMed ID: 7593453
    [Abstract] [Full Text] [Related]

  • 11. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M, Frohman LA.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of tumor-induced hypoglycemia with intraabdominal hemangiopericytoma.
    Chung J, Henry RR.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):919-25. PubMed ID: 8772551
    [Abstract] [Full Text] [Related]

  • 13. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA, Cryer PE, Gerich JE.
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [Abstract] [Full Text] [Related]

  • 14. Isoproterenol and somatostatin decrease plasma leptin in humans: a novel mechanism regulating leptin secretion.
    Donahoo WT, Jensen DR, Yost TJ, Eckel RH.
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4139-43. PubMed ID: 9398728
    [Abstract] [Full Text] [Related]

  • 15. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS, Ho LT.
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin release in response to glucose is impaired in chronic renal failure.
    Franceschini R, Robaudo C, Corsini G, Cataldi A, Bruno E, Russo R, Rolandi E, Barreca T.
    Biomed Pharmacother; 1998 Jun; 52(5):208-13. PubMed ID: 9755817
    [Abstract] [Full Text] [Related]

  • 17. Effects of amino acids on glucose disposal.
    Boden G, Tappy L.
    Diabetes; 1990 Sep; 39(9):1079-84. PubMed ID: 1974539
    [Abstract] [Full Text] [Related]

  • 18. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S, Pemberton C, Hunt P, Cole D, Raudsepp S, Inder W.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [Abstract] [Full Text] [Related]

  • 19. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
    Egan JM, Meneilly GS, Habener JF, Elahi D.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.
    Kelijman M, Williams TC, Downs TR, Frohman LA.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):958-63. PubMed ID: 2903171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.